Page last updated: 2024-10-30

mepivacaine and Spinal Cord Diseases

mepivacaine has been researched along with Spinal Cord Diseases in 1 studies

Mepivacaine: A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
mepivacaine : A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.

Spinal Cord Diseases: Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Margolis, G1
Yerasimides, TG1

Other Studies

1 other study available for mepivacaine and Spinal Cord Diseases

ArticleYear
Vasopressor potentiation of neurotoxicity in experimental aortography. Implications regarding pathogenesis of contrast medium injury.
    Acta radiologica: diagnosis, 1966, Volume: 5

    Topics: Animals; Aortography; Contrast Media; Dogs; Mepivacaine; Norepinephrine; Paralysis; Seizures; Spinal

1966